NCT07069894View on ClinicalTrials.gov

Effect of Xuebijing InjecTion on Outcomes in Sepsis Patients Under Real-World Conditions（EXIT-SEP REAL）

Not yet recruitingOBSERVATIONAL

Enrollment

5,400

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

September 30, 2027

Conditions

Sepsis

Trial Locations (1)

210009

Zhongda hospital, Southeast University, Nanjing

All Listed Sponsors

lead

Southeast University, China

OTHER

NCT07069894 - Effect of Xuebijing InjecTion on Outcomes in Sepsis Patients Under Real-World Conditions（EXIT-SEP REAL） | Biotech Hunter | Biotech Hunter